NCT04402112View on ClinicalTrials.gov

Efficacy and Safety of Pitavastatin in a Real-world Setting

CompletedOBSERVATIONAL

Enrollment

28,343

Participants

Timeline

Start Date

April 2, 2012

Primary Completion Date

April 1, 2017

Study Completion Date

August 1, 2017

Conditions

Hypercholesterolemia

Interventions

DRUG

Pitavastatin

1mg, 2mg, or 4mg, Once a day, at least 8 weeks

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY